• hESCs overexpressing the 31 kD FGF2 isoform significantly enhance motoneuron survival and functional recovery after spinal root avulsion.
• The combination of hESC therapy with heterologous fibrin biopolymer (HFB) provides a promising scaffold for cell delivery and root repair.
• The 31 kD FGF2 isoform outperforms 18 and 23 kD isoforms in neuroprotection, immunomodulation, and attenuation of astrogliosis.
• This approach offers a novel therapeutic strategy for preganglionic spinal root injuries, potentially improving quality of life and reducing treatment costs.